V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20165391 | 20063429 | 1.52 | 45 | Neo-adjuvant (N) | 2016-02-07 | 2016-02-13 | ECX | N | N | ECX | 101861066 |
| 20165392 | 20063430 | 1.71 | 47 | Adjuvant (A) | 2017-08-21 | 2017-08-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101292434 |
| 20165395 | 20063431 | 1.77 | 69.2 | null | 2016-09-14 | 2016-09-28 | ECX | 2 | N | ECX | 101148593 |
| 20165399 | 20063432 | 1.56 | 90.4 | Neo-adjuvant (N) | 2018-01-05 | 2018-01-05 | ECX | null | N | ECX | 100096982 |
| 20165400 | 20063433 | 1.6 | 46 | Palliative (P) | 2017-07-31 | 2017-08-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101528569 |
| 20165401 | 20063434 | 1.7 | 75 | Adjuvant (A) | 2019-08-31 | 2019-09-26 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101487159 |
| 20165403 | 20063435 | 1.62 | 57 | Palliative (P) | 2016-08-30 | 2016-09-14 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100873101 |
| 20165404 | 20063436 | 1.6 | 59.4 | Neo-adjuvant (N) | 2017-03-06 | 2017-03-15 | ECX | N | N | ECX | 100915686 |
| 20165407 | 20063437 | null | null | Palliative (P) | 2016-03-26 | 2016-03-27 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100900145 |
| 20165412 | 20063438 | 1.63 | 43.6 | Palliative (P) | 2019-10-19 | 2019-10-23 | ECX | 02 | N | ECX | 100142704 |
| 20165413 | 20063439 | 1.73 | 68.7 | Adjuvant (A) | null | 2018-03-26 | Gemcitabine + Capecitabine | Y | N | CAPECITABINE + GEMCITABINE | 100728998 |
| 20165414 | 20063440 | 1.58 | 77.2 | Adjuvant (A) | 2019-03-22 | 2019-04-04 | ECX | null | null | ECX | 100765847 |
| 20165416 | 20063441 | 1.71 | 71.35 | Neo-adjuvant (N) | 2016-07-09 | 2016-07-29 | ECX | N | N | ECX | 100599174 |
| 20165435 | 20063442 | 1.98 | 88 | Palliative (P) | 2018-10-17 | 2018-10-17 | Gemcitabine + Capecitabine | N | N | ECX | 100484093 |
| 20165438 | 20063443 | 1.56 | 77.9 | Neo-adjuvant (N) | 2019-10-19 | 2019-10-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101475933 |
| 20165440 | 20063444 | 1.82 | 59 | Adjuvant (A) | 2017-06-16 | 2017-06-30 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100889629 |
| 20165442 | 20063445 | 1.7 | 75.9 | Palliative (P) | 2018-11-10 | 2018-11-13 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100715005 |
| 20165443 | 20063446 | 1.7 | 61.2 | null | 2019-11-27 | 2019-12-11 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100989814 |
| 20165452 | 20063447 | 1.68 | 81.4 | Palliative (P) | 2017-03-03 | 2017-03-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101433698 |
| 20165458 | 20063448 | 1.85 | 52.8 | Neo-adjuvant (N) | 2016-03-22 | 2016-04-02 | ECX | 2 | N | ECX | 100792427 |
| 20165459 | 20063449 | 1.63 | 36.6 | Palliative (P) | 2019-11-13 | 2019-11-18 | ECX | N | N | ECX | 101445900 |
| 20165462 | 20063450 | 1.66 | 80.1 | Adjuvant (A) | 2018-09-18 | 2018-09-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101327095 |
| 20165463 | 20063451 | 1.73 | 77.9 | Neo-adjuvant (N) | 2018-06-22 | 2018-06-26 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100947200 |
| 20165472 | 20063452 | 1.57 | 81.2 | null | 2016-10-16 | 2016-10-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100046716 |
| 20165477 | 20063453 | 1.77 | 71 | Palliative (P) | 2018-10-10 | 2018-10-18 | ECX | 2 | N | ECX | 101115462 |
| 20165483 | 20063454 | 1.73 | 66.9 | Adjuvant (A) | 2017-09-24 | 2017-09-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101747627 |
| 20165492 | 20063455 | null | null | null | 2016-05-10 | 2016-06-07 | ECX | N | null | CAPECITABINE + GEMCITABINE | 100560290 |
| 20165495 | 20063456 | 1.61 | 68.4 | Adjuvant (A) | 2018-10-08 | 2018-11-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101407353 |
| 20165496 | 20063457 | 1.7 | 78.55 | Palliative (P) | 2016-05-04 | 2016-05-05 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101056232 |
| 20165497 | 20063458 | 1.72 | 70 | Neo-adjuvant (N) | 2016-06-26 | 2016-06-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101519182 |
| 20165499 | 20063459 | 1.69 | 95.9 | Curative (C) | null | 2018-01-04 | ECX | null | N | ECX | 100912313 |
| 20165514 | 20063460 | 1.6 | 41 | Neo-adjuvant (N) | null | 2016-11-13 | ECX | 1 | N | ECX | 100270748 |
| 20165521 | 20063461 | 1.56 | 76 | Palliative (P) | 2019-03-07 | 2019-03-16 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100811278 |
| 20165529 | 20063462 | 1.78 | 76 | Adjuvant (A) | 2019-03-13 | 2019-04-04 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100472443 |
| 20165545 | 20063463 | 1.76 | 71.7 | Palliative (P) | 2019-11-19 | 2019-12-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100100493 |
| 20165546 | 20063464 | 1.6 | 53.3 | Neo-adjuvant (N) | 2018-05-25 | 2018-05-30 | ECX | 02 | N | ECX | 100004678 |
| 20165547 | 20063465 | 1.74 | 87 | Neo-adjuvant (N) | 2018-10-12 | 2018-10-19 | ECX | 02 | N | ECX | 100750348 |
| 20165555 | 20063466 | 1.66 | 50 | Adjuvant (A) | 2017-03-16 | 2017-03-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100104574 |
| 20165556 | 20063467 | 1.65 | 87.7 | Palliative (P) | 2016-09-07 | 2016-10-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101133101 |
| 20165557 | 20063468 | 1.65 | 59 | Palliative (P) | 2016-11-02 | 2016-11-17 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101860311 |
| 20165567 | 20063469 | 1.64 | null | null | 2016-11-30 | 2016-12-22 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100892730 |
| 20165572 | 20063470 | 1.56 | 77.4 | Adjuvant (A) | 2017-08-02 | 2017-08-02 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100668439 |
| 20165573 | 20063471 | 1.73 | 58.3 | Neo-adjuvant (N) | 2017-08-15 | 2017-08-15 | ECX | 02 | N | ECX | 101767388 |
| 20165574 | 20063472 | 1.65 | 80.4 | Curative (C) | 2018-11-26 | 2018-11-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100671228 |
| 20165579 | 20063473 | 1.75 | 119.8 | null | 2016-02-01 | 2016-02-19 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100419286 |
| 20165587 | 20063474 | 1.78 | 78 | Adjuvant (A) | 2016-02-07 | 2016-02-07 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100109193 |
| 20165591 | 20063475 | 1.54 | 66.3 | Adjuvant (A) | 2019-09-27 | 2019-10-11 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100439032 |
| 20165594 | 20063476 | 1.83 | 59.1 | Neo-adjuvant (N) | 2017-05-31 | 2017-06-08 | ECX | N | N | ECX | 101455181 |
| 20165596 | 20063477 | 1.72 | 72.9 | Palliative (P) | null | 2018-10-04 | Gemcitabine + Capecitabine | 99 | N | CAPECITABINE + GEMCITABINE | 100998022 |
| 20165597 | 20063478 | 1.77 | 76 | Palliative (P) | 2016-04-27 | 2016-04-29 | ECX | 02 | N | ECX | 100492339 |